Health care costs associated with Australian tertiary inflammatory bowel disease care

References

• Jewell DP, Satsangi J, Lobo A, et al. Infliximab use in Crohn's disease: impact on health care resources in the UK. Eur J Gastroenterol Hepatol. 2005;17:1047–1052.
   PubMed Web of Science ®Google Scholar
• Wilson J, Hair C, Knight R, et al. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflammatory Bowel Diseases. 2010;16:1550–1556.
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54 e42. quiz e30.
   PubMed Web of Science ®Google Scholar
• Jess T, Frisch M, Simonsen J. Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol: Off Clin Practice J Am Gastroenterol Assoc. 2013;11:43–48.
   PubMed Web of Science ®Google Scholar
• Hoivik ML, Moum B, Solberg IC, et al. Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study. Gut. 2013;62:368–375.
   PubMed Web of Science ®Google Scholar
• Bodger K. Cost of illness of Crohn's disease. Pharmacoeconomics. 2002;20:639–652.
   PubMed Web of Science ®Google Scholar
• PriceWaterhouseCoopers. Improving Inflammatory Bowel Disease care across Australia. Crohn's & Colitis Australia 2013.
   Google Scholar
• Croft LJ, Rankin PM, Liegeois F, et al. To speak, or not to speak? The feasibility of imaging overt speech in children with epilepsy. Epilepsy Res. 2013;107:195–199.
   PubMed Web of Science ®Google Scholar
• Croft A, Walsh A, Doecke J, et al. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab. Aliment Pharmacol Ther. 2013;38:294–302.
   PubMed Web of Science ®Google Scholar
• van Langenberg DR, Simon SB, Holtmann GJ, et al. The burden of inpatient costs in inflammatory bowel disease and opportunities to optimize care: a single metropolitan Australian center experience. J Crohn's Colitis. 2010;4:413–421.
   Google Scholar
• Niewiadomski O, Studd C, Hair C, et al. Health care cost analysis in a population based inception cohort of Inflammatory Bowel Disease patients in the first year of diagnosis. J Crohn's Colitis. 2015;9:988–996
   Google Scholar
• Wright EK, Kamm MA, Dr Cruz P, et al. Cost-effectiveness of Crohn's disease post-operative care. World J Gastroenterol. 2016;22:3860–3868.
   PubMed Web of Science ®Google Scholar
• WHO Classifications. 2016 [cited 2016 May 3]. Available at http://www.who.int/classifications/icd/en/).
   Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753.
   PubMed Web of Science ®Google Scholar
• Chapko MK, Liu CF, Perkins M, et al. Equivalence of two healthcare costing methods: bottom-up and top-down. Health Econ. 2009;18:1188–1201.
   PubMed Web of Science ®Google Scholar
• Cooper R, Kaplan RS, Measure costs right: make the right decisions. Harvard Business Rev. 1988; September–October 1988;60:85–103.
   Google Scholar
• Kaplan RS, Anderson SR, Time-driven activity-based costing: a simpler and more powerful path to higher profits. Harvard: Harvard Business Press. 2013.
   Google Scholar
• Hovenga EJ, Health informatics: an overview. Amsterdam: IOS Press; 2010.
   Google Scholar
• Medicare Benefits Schedule. 2016 [cited 2016 May 4]. Available at http://www.mbsonline.gov.au/.
   Google Scholar
• Ma R, Hospital purchase cost for Austin Health, Australia; 2014.
   Google Scholar
• Australian Government Department of Health. The Pharmaceutical Benefits Scheme; 2016.
   Google Scholar
• van der Valk ME, Mangen MJ, Leenders M, et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study. Gut. 2014;63:72–79.
   PubMed Web of Science ®Google Scholar
• Bassi A, Dodd S, Williamson P, et al. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut. 2004;53:1471–1478.
   PubMed Web of Science ®Google Scholar
• Gibson PR, Vaizey C, Black CM, et al. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study. J Crohn's Colitis. 2014;8:598–606.
   Google Scholar
• Ghosh N, Premchand P, A UK cost of care model for inflammatory bowel disease. Frontline Gastroenterol. 2015;6:169–174.
   Google Scholar
• Bodger K, Yen L, Szende A, et al. Medical resource utilization and associated costs in patients with ulcerative colitis in the UK: a chart review analysis. Eur J Gastroenterol Hepatol. 2014;26:213–221.
   PubMed Web of Science ®Google Scholar
• Bodger K. Cost effectiveness of treatments for inflammatory bowel disease. Pharmacoeconomics. 2011;29:387–401.
   PubMed Web of Science ®Google Scholar
• Group TIS, Standards for the Healthcare of People who have Inflammatory Bowel Disease (IBD); 2013.
   Google Scholar
• Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol. 1992;14:309–317.
   PubMed Web of Science ®Google Scholar
• Feagan BG, Vreeland MG, Larson LR, et al. Annual cost of care for Crohn's disease: a payor perspective. Am J Gastroenterol. 2000;95:1955–1960.
   PubMed Web of Science ®Google Scholar
• Blomqvist P, Ekbom A. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol. 1997;32:1134–1139.
   PubMed Web of Science ®Google Scholar
• Limited AEP, The economic costs of Crohn's disease and Ulcerative Colitis; 2007.
   Google Scholar
• Sack C, Phan VA, Grafton R, et al. A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease. J Crohn's Colitis. 2012;6:302–310.
   Google Scholar
• Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996;74:511–544.
   PubMed Web of Science ®Google Scholar